28 Ray Dalio United Therapeutics Trades
Ray Dalio acquired 195k United Therapeutics shares worth $74.2M. That's 0.29% of their equity portfolio (69th largest holding). The first United Therapeutics trade was made in Q4 2015. Since then Ray Dalio bought shares sixteen more times and sold shares on eleven occasions. The stake costed the investor $60.4M, netting the investor a gain of 23% so far.
Avg closing price
Price range
Increased shares by 0.7% (+1.33k shares)
Q2 2025
Avg closing price
$298.71
Price range
$276.47
-
$328.40
Increased shares by 79.9% (+86.1k shares)
Q1 2025
Avg closing price
$343.78
Price range
$304.42
-
$380.78
Increased shares by 74.4% (+46k shares)
Q4 2024
Avg closing price
$367.42
Price range
$348.65
-
$410.00
Increased shares by 384.3% (+49k shares)
Q3 2024
Avg closing price
$337.78
Price range
$311.04
-
$363.55
Increased shares by 60.4% (+4.8k shares)
Q2 2024
Avg closing price
$264.67
Price range
$228.26
-
$319.04
Sold 11.9% shares (-1.07k shares)
Q1 2024
Avg closing price
$225.66
Price range
$210.76
-
$249.51
Sold 50.3% shares (-9.13k shares)
Q4 2023
Avg closing price
$230.49
Price range
$214.88
-
$256.94
Sold 55.5% shares (-22.7k shares)
Q3 2023
Avg closing price
$230.33
Price range
$211.82
-
$248.24
Sold 1.1% shares (-460 shares)
Q2 2023
Avg closing price
$221.50
Price range
$205.19
-
$232.99
Increased shares by 64.4% (+16.2k shares)
Q1 2023
Avg closing price
$246.53
Price range
$212.99
-
$276.17
Sold 43.2% shares (-19.1k shares)
Q4 2022
Avg closing price
$252.44
Price range
$205.95
-
$280.43
Sold 18.8% shares (-10.2k shares)
Q3 2022
Avg closing price
$223.56
Price range
$203.30
-
$244.17
New holding (+54.4k shares)
Q2 2022
Avg closing price
$203.30
Price range
$174.81
-
$241.14
Sold -9.12k shares
Q2 2019
Avg closing price
$93.51
Price range
$76.06
-
$120.81
New holding (+9.12k shares)
Q1 2019
Avg closing price
$116.52
Price range
$107.15
-
$126.84
Sold -53.7k shares
Q4 2018
Avg closing price
$115.95
Price range
$101.40
-
$128.73
Increased shares by 18.5% (+8.4k shares)
Q3 2018
Avg closing price
$123.69
Price range
$113.81
-
$129.46
Sold 71.9% shares (-116k shares)
Q2 2018
Avg closing price
$109.92
Price range
$101.14
-
$118.31
Increased shares by 72.2% (+67.6k shares)
Q1 2018
Avg closing price
$127.04
Price range
$107.21
-
$151.94
Increased shares by 1.0% (+953 shares)
Q4 2017
Avg closing price
$127.12
Price range
$118.58
-
$151.28
News about United Therapeutics Corp and Ray Dalio
Bridgewater Associates LP Cuts Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
Bridgewater Associates LP lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR ¨C Free Report) by 1.1% in the 2nd quarter, according to its mo...